Allschwil, Switzerland

William Leonard Wishart

This inventor holds 3 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William Leonard Wishart. Retrieved from https://idiyas.com/inventor/william-leonard-wishart

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator in Neurological Treatments: William Leonard Wishart

Introduction

William Leonard Wishart is an accomplished inventor based in Allschwil, Switzerland. With a focus on developing innovative solutions in the field of pharmaceuticals, he has secured three patents that contribute significantly to the advancement of neurological treatments. His work aims to address critical issues related to axonal degeneration and demyelination.

Latest Patents

Among his latest innovations, Wishart's patent titled "LINGO binding molecules and pharmaceutical use thereof" is particularly noteworthy. This invention involves a binding molecule capable of interacting with LINGO polypeptides found in rats, cynomolgus monkeys, and humans. It includes the development of an expression vector and a comprehensive expression system for the production of the binding molecule. Additionally, it outlines methods for utilizing these molecules in pharmaceutical compositions aimed at promoting axonal regeneration and plasticity. Furthermore, the invention provides a treatment method for diseases linked to axonal degeneration and demyelination.

Another significant patent of Wishart is concerned with "Treatment of neurological disorders by dsRNA administration." This invention proposes a method involving the intrathecal injection of double-stranded RNA (dsRNA) to treat various neurological disorders. The dsRNA is designed to inhibit the expression of target genes, thereby offering a novel therapeutic avenue for patients in need.

Career Highlights

William Leonard Wishart contributes his expertise to Novartis AG, a leading global healthcare company known for its innovative approaches in pharmaceuticals. His role within the organization allows him to work at the forefront of medical research and development, ultimately benefiting patients with neurological conditions.

Collaborations

Throughout his career, Wishart has collaborated with esteemed colleagues such as Gabriele Dorn and Pamposh Ganju. These partnerships have fostered a productive environment for innovation and have been essential in advancing his research endeavors.

Conclusion

William Leonard Wishart is a pioneering inventor whose contributions to neurological treatment innovations are paving the way for new therapeutic strategies. His patents offer hope for improved treatments for patients grappling with conditions related to axonal degeneration and demyelination. As medical research continues to evolve, Wishart's work exemplifies the critical role of inventive minds in shaping the future of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…